Top Wall Street analysts have changed their view of these top companies. For details on all Analyst Rating changes, including upgrades and downgrades, please visit our Analyst Ratings page.
- Goldman Sachs analyst Toshiya Hari upgraded the rating. teradyne company. TER We changed the rating from Neutral to Buy, while increasing the price target from $118 to $161. Teradyne stock closed Friday at $131.91. See what other analysts think about this stock.
- Morgan Stanley analyst Joseph Moore upgrades the rating. Micron Technology Co., Ltd. Mu We upgraded the stock to equal weight from underweight and raised our price target from $98 to $130. Micron shares fell 2% Friday to settle at $125.29. See what other analysts think about this stock.
- Piper Sandler analyst Matt O'Brien said: Globus Medical Co., Ltd.. GMED From Neutral to Overweight, price target raised from $60 to $80. Globus Medical stock rose 0.7% on Friday, settling at $64.40. See what other analysts think about this stock. See what other analysts think about this stock.
- Upgrades Jefferies analyst John Colantuoni MercadoLibre Inc.. Meri He switched the stock from hold to buy and announced a price target of $2,100. MercadoLibre stock closed Friday at $1,749.17. See what other analysts think about this stock.
- UBS analyst AJ Rice upgraded the rating. Universal Health Service Co., Ltd.. UHS They changed their rating from Neutral to Buy, while raising their price target from $189 to $226. Universal Health stock settled at $177.70 on Friday. See what other analysts think about this stock.
Check this: DR Horton, Netflix, 3 stocks to watch on Thursday
Latest evaluation of MU
date | hard | action | from | to |
---|---|---|---|---|
February 2022 | wedbush | upgrade | neutral | excellent |
January 2022 | goldman sachs | maintain | buy | |
January 2022 | new street research | Date to start coverage | buy |
See more analyst ratings for MU
View the latest analyst ratings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.